Search for: "Mallinckrodt Inc." Results 1 - 20 of 84
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 May 2019, 9:58 pm by Patent Docs
Noonan -- Last Friday, the Federal Circuit affirmed a decision by the District Court that Defendants Actavis LLC and Teva Pharmaceuticals did not show by clear and convincing evidence that the claims asserted by Endo Pharmaceuticals Inc. and Mallinckrodt LLC were obvious, in Endo Pharmaceuticals Inc. v. [read post]
17 Sep 2017, 6:00 am by Steve Brachmann
Prometheus Laboratories, Inc., a standard affirmed by SCOTUS’ 2014 decision in Alice Corporation v. [read post]
12 Sep 2013, 3:12 am by Robert Kraft
Mallinckrodt Inc., 13-cv-05831, US District Court, Southern District of New York (Manhattan). [read post]
4 May 2019, 2:55 pm by Lawrence B. Ebert
Mallinckrodt then claimed thisrequirement in the ’779 patent. [read post]
25 Jun 2018, 7:33 am
Lexmark, The Overruling of Mallinckrodt and The Future of Restraints on Alienation For Patented GoodsJames B. [read post]
28 Sep 2014, 9:59 pm by Patent Docs
InnoPharma Licensing LLC et al. 1:14-cv-01225; filed September 24, 2014 in the District Court of Delaware • Plaintiffs: Cadence Pharmaceuticals Inc.; SCR Pharmatop; Mallinckrodt IP • Defendants: InnoPharma Licensing LLC; InnoPharma Inc. [read post]
4 Dec 2019, 9:15 am by J. Morgan Kirley
Earlier this month, Mallinckrodt succeeded in its inter partes review (IPR) challenge against patent owner Biovie, Inc. [read post]
2 Oct 2020, 7:50 am by Renae Lloyd
As a result of the completed merger, Ocera became an indirect, wholly owned subsidiary of Mallinckrodt. [read post]